A nurse is preparing to administer levothyroxine 50 mcg to a client. Available is levothyroxine 0.025 mg/tablet. How many tablets should the nurse administer per dose? (Round to the nearest whole number. Use a leading zero if it applies. Do not use a trailing zero.)

A. Potential complications. The provider is responsible for informing the client of possible risks and complications associated with the procedure. This ensures the client understands what to expect and can make an informed decision.
B. Cost of the procedure. While cost is an important consideration, it is not part of the informed consent process that the provider must explain. Financial discussions are typically handled by billing or administrative personnel.
C. Possible alternative treatments. Informed consent includes a discussion of reasonable alternatives so the client can weigh all available options. This allows for autonomous decision-making regarding their care.
D. Explanation of the procedure. The provider must describe the nature and details of the procedure, including what it involves and how it will be performed. This ensures the client understands what they are consenting to.
E. Expected outcome of the procedure. Clients should be informed of the anticipated results and benefits of the surgery. This helps set realistic expectations and supports informed decision-making.

A. Diplopia. Double vision (diplopia) is more commonly associated with neurological or ophthalmic disorders such as multiple sclerosis or cranial nerve dysfunction. It is not a typical manifestation of lupus exacerbations.
B. Fever. Fever is a common and expected finding during an acute exacerbation of systemic lupus erythematosus (SLE). It results from systemic inflammation and immune system activation, often indicating disease flare-up or potential infection.
C. Esophagitis. Esophagitis is more often linked to gastroesophageal reflux disease or infections, not systemic lupus. Although lupus can affect many organs, the esophagus is not a typical site of acute involvement in SLE exacerbations.
D. Bradykinesia. Bradykinesia, or slowness of movement, is a hallmark feature of Parkinson’s disease. It is not associated with SLE and would not be expected during a lupus flare.